Analyst Ratings for Diplomat Pharmacy Inc. (DPLO)

Updated: 2017-07-27

Shares of Diplomat Pharmacy Inc. (NYSE:DPLO) have received a consensus rating of Hold from Wall Street analysts. DPLO had previously received a consensus rating of Hold a month ago.

A buy rating was issued by 3 analysts, 1 gave an overweight rating, 7 issued a hold rating, 0 gave an underweight rating, and 1 issued a sell rating. Compared to three months ago, there has been an increase of 1 in the number of analysts with a positive outlook on the stock. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Many analysts weighed in on price targets for DPLO. The highest price target was 20, which equates to a potential upside of 28.87 percent. The lowest price target was 11, implying a possible loss of -29.12 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 3.33 percent. That number becomes -3.12 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised downwards by -1.52 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of 1.56 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 1 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 0 analysts that decreased their estimates. During this time, 1 analysts made positive revisions in their estimates for this fiscal year's earnings, while 2 analysts decreased their estimates.

DPLO has an estimated earnings growth rate of 155.68 percent as forecasted by analysts. Another measure frequently examined by investors is the PEG ratio. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. PEG ratios below 1 are often considered desirable, though it could be better to see where the ratio stands relative to peers in the industry. DPLO has a PEG ratio of 0.4.

In the trailing 52-weeks, DPLO hit 38.94 at the highest peak, while it's lowest trading point was 12.25. The current market price is above the trailing year's low by 26.69 percent, and below the high by 60.14 percent. DPLO has a price/earnings ratio of 62.08. Investors typically compare the P/E ratio to a company's peers in the industry. The DPLO value stock report compares DPLO to some of its peers using value stock charts. The market cap of DPLO is $1.06 billion. DPLO is estimated to release their earnings results for the quarter on 0000-00-00, days from today.